Cargando…
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Squamous cell carcinoma (SCC) is the most common cancer worldwide. The treatment of locally advanced disease generally requires various combinations of radiotherapy, surgery, and systemic therapy. Despite aggressive multimodal treatment, most of the patients relapse. Identification of molecules that...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415770/ https://www.ncbi.nlm.nih.gov/pubmed/28536639 http://dx.doi.org/10.1186/s11658-017-0038-0 |